Stereotactic body radiotherapy (SBRT) versus androgen deprivation therapy (ADT) for oligometastatic prostate cancer: protocol for a prospective randomised control clinical trial.
Xianzhi ZhaoTao WangYusheng YeJing LiXu GaoHuojun ZhangPublished in: BMJ open (2022)
Clinicaltrials.gov identifier:NCT04599686.